Robert Francomano serves as Executive at STEMLINE THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Robert Francomano has executed 12 insider transactions totaling $72.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2024 involved receiving (via award) 20,000 shares valued at $0.
Robert Francomano currently holds 40,918 shares of STEMLINE THERAPEUTICS INC (STML), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Francomano has been a net seller of STML stock. They have purchased $0 and sold $72.4K worth of shares.
Robert Francomano's most recent insider trade was on Jan 22, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.08 |
| Discretionary |
| Feb 2, 2023 | SLS | $0 | Award | 12,000 | $N/A | Discretionary |
| Jun 10, 2020 | STML | $0 | Tender | 200,891 | $N/A | Discretionary |
| May 4, 2020 | STML | $3.1K | Sale | 272 | $11.51 | Discretionary |
| Mar 9, 2020 | STML | $6.3K | Sale | 1,266 | $5.00 | Discretionary |
| Feb 10, 2020 | STML | $0 | Award | 105,939 | $N/A | Discretionary |
| Feb 7, 2020 | STML | $34.0K | Sale | 5,064 | $6.72 | Discretionary |
| Dec 27, 2019 | STML | $1.2K | Sale | 116 | $10.48 | Discretionary |
| Dec 26, 2019 | STML | $9.6K | Sale | 893 | $10.75 | Discretionary |
| Dec 24, 2019 | STML | $15.5K | Sale | 1,412 | $10.97 | Discretionary |
| Dec 23, 2019 | STML | $2.6K | Sale | 249 | $10.58 | Discretionary |